FMD K&L Europe unit in Yerevan, Armenia conducts workshops on the topic of “Experience and Potential of GCP clinical trials in Armenia” since May, 2016.
This is the first step towards a new bright future of Armenia Bio-industry, which also attracts the attention of Armenian local media-news.am. The following is the article written in the website of news.am.
Yerevan Hosts Seminars on Clinical Research
12 July, 19:40
Yerevan hosts seminars on “Experience and Potential of GCP clinical trials in Armenia”, organized by FMD KL Europe Contract Research Organization in cooperation with Armenian Association of Young Doctors.
FMD KL Europe Business Development Specialist Alla Aristakesyan mentioned to NEWS.am Medicine reporter that the aim of the seminars is to share knowledge of conducting GCP (Good Clinical Practice) clinical trials in compliance with standards that are globally adopted, as well as to share the experience and potential of conducting such clinical trials in Armenia. Alla Aristakesyan briefed that the Seminar-Workshop is organized in the scope of the “Armenian Biotech Development Forum” long-term state project and the international forum that is going to take place in the near future.
It is worth mentioning that the program of the seminars has been approved by the RA Ministry of Health and the participants will receive 2 CME credits and nominal certificates.
Note that GCP standard is international standard on ethical norms and quality of scientific researches, which covers rules on research initiation, conduction, documentation and the preparation of reports of studies that involve human participants.
These rules have been formulated in ICH (International Conference on Harmonization) and the Declaration of Helsinki.
Like GMP (Good Manufacturing Practice) and GLP (Good Laboratory Practice), GCP is meant to standardize some aspects of the medical service of the population. GCP, GMP and GLP are considered to be “three whales” of evidence-based medicine.